Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Disease-modifying drugs for multiple sclerosis and JC virus expression.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
A controlled trial of natalizumab for relapsing multiple sclerosis.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Exercise and quality of life in women with multiple sclerosis.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
miRNA in multiple sclerosis: search for novel biomarkers.
CD4 cell response to interval therapy with natalizumab.
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Central nervous system lymphoma associated with natalizumab.

Pages